Robert Gramling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Gramling has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Justin Nash
2 shared publications- Larry Culpepper
Boston University School of Medicine, Boston, MA, USA
2 shared publications - Charles B. Eaton
Warren Alpert Medical School of Brown University
1 shared publication David Anthony
Brown Medical School, Providence, RI, USA
1 shared publicationDeborah Bowen
Fred Hutchinson Cancer Institute, Seattle, WA, USA
1 shared publicationGeorita Frierson
Cooper Institute, Dallas, TX, USA
1 shared publication
Latest Publications
- 1 January 2007
- Published by SAGE Publications in American Journal of Lifestyle Medicine
- Vol. 1 (1) , 54-58
Risk Communication During Screening for Genomic Breast Cancer Susceptibility
Screening for genomic predisposition to diseases of adulthood is emerging in standard medical practice. Breast cancer predisposition testing provides a useful example for understanding the potential implications of risk-related screening in practice. Risk is an important and complex psychological construct that is understood differently both between scientific disciplines and between medical and lay persons. The process of establishing thresholds for classifying whether one's risk reaches levels warranting departure from standard preventive strategies is an important predictor of both physician feedback and patient interpretation of their risk. Messages about genomic breast cancer risk arising during the pedigree screening context are conveyed via explicit and implicit modes of communication. Best practices for communicating about genomic risk and the implications for health disparities related to screening for genomic susceptibility remain unknown. More work is urgently needed given the societal forces that are catalyzing population-based screening for genomic predisposition into the routine practice of preventive medicine.
- 1 January 2007
- Published by SAGE Publications in American Journal of Lifestyle Medicine
- Vol. 1 (1) , 54-58
Risk Communication During Screening for Genomic Breast Cancer Susceptibility
Screening for genomic predisposition to diseases of adulthood is emerging in standard medical practice. Breast cancer predisposition testing provides a useful example for understanding the potential implications of risk-related screening in practice. Risk is an important and complex psychological construct that is understood differently both between scientific disciplines and between medical and lay persons. The process of establishing thresholds for classifying whether one's risk reaches levels warranting departure from standard preventive strategies is an important predictor of both physician feedback and patient interpretation of their risk. Messages about genomic breast cancer risk arising during the pedigree screening context are conveyed via explicit and implicit modes of communication. Best practices for communicating about genomic risk and the implications for health disparities related to screening for genomic susceptibility remain unknown. More work is urgently needed given the societal forces that are catalyzing population-based screening for genomic predisposition into the routine practice of preventive medicine.
- 10 November 2006
- Published by Wiley in Psycho-Oncology
- Vol. 16 (6) , 593-597
The cancer worry chart: a single‐item screening measure of worry about developing breast cancer
Background: Brief pictograph measures of health functioning have clinical value to office‐based practice. Many women with a close family history of breast cancer will experience worry about their risk of developing breast cancer that influences decision‐making and can interfere with health‐related functioning.Purpose: To develop a clinically ‐ useful triage measure of breast cancer worry for the field setting of office based practice.Methods: Design: qualitative pilot testing followed by mailed survey. Survey sample: women registered with the Cancer Genetics Network who have a first or second‐degree family history of breast cancer and no personal history of any cancer. Novel measure: single pictograph item modeled upon the Dartmouth COOP Charts. Comparison gold‐standard measure: four‐item Cancer Worry Scale (CWS).Results: Pilot testing: participants found the item to be easily understood, rapidly completed and unobtrusive. Quantitative: 469 women responded (78% response rate); the Cancer Worry Chart demonstrated strong correlation to the CWS (Pearson correlation coefficient: 0.66, P < 0.001); Receiver operator curve identified favorable characteristics (AUC = 0.86) of the Cancer Worry Chart for identifying cancer worry‐related mood or social role dysfunction.Conclusions: The new Cancer Worry Chart is a valid triage measure for breast cancer worry. Copyright © 2006 John Wiley & Sons, Ltd.
- 10 November 2006
- Published by Wiley in Psycho-Oncology
- Vol. 16 (6) , 593-597
The cancer worry chart: a single‐item screening measure of worry about developing breast cancer
Background: Brief pictograph measures of health functioning have clinical value to office‐based practice. Many women with a close family history of breast cancer will experience worry about their risk of developing breast cancer that influences decision‐making and can interfere with health‐related functioning.Purpose: To develop a clinically ‐ useful triage measure of breast cancer worry for the field setting of office based practice.Methods: Design: qualitative pilot testing followed by mailed survey. Survey sample: women registered with the Cancer Genetics Network who have a first or second‐degree family history of breast cancer and no personal history of any cancer. Novel measure: single pictograph item modeled upon the Dartmouth COOP Charts. Comparison gold‐standard measure: four‐item Cancer Worry Scale (CWS).Results: Pilot testing: participants found the item to be easily understood, rapidly completed and unobtrusive. Quantitative: 469 women responded (78% response rate); the Cancer Worry Chart demonstrated strong correlation to the CWS (Pearson correlation coefficient: 0.66, P < 0.001); Receiver operator curve identified favorable characteristics (AUC = 0.86) of the Cancer Worry Chart for identifying cancer worry‐related mood or social role dysfunction.Conclusions: The new Cancer Worry Chart is a valid triage measure for breast cancer worry. Copyright © 2006 John Wiley & Sons, Ltd.
- Open Access
- 1 March 2004
- Published by Annals of Family Medicine in The Annals of Family Medicine
- Vol. 2 (2) , 130-132
Family Physician Self-Efficacy With Screening for Inherited Cancer Risk
BACKGROUND Recent evidence has shown low and inconsistent rates of family history screening among generalist physicians. Little has been done to investigate the physician factors likely to mediate this behavior. We investigated family physicians’ beliefs about screening their patients for inherited cancer risk, measuring their perceptions of self-efficacy and the importance of screening.
- 1 March 2004
- Published by Annals of Family Medicine in The Annals of Family Medicine
- Vol. 2 (2) , 130-132
Open AccessFamily Physician Self-Efficacy With Screening for Inherited Cancer Risk
BACKGROUND Recent evidence has shown low and inconsistent rates of family history screening among generalist physicians. Little has been done to investigate the physician factors likely to mediate this behavior. We investigated family physicians’ beliefs about screening their patients for inherited cancer risk, measuring their perceptions of self-efficacy and the importance of screening.
- 1 September 2003
- Vol. 52 (9) , 667-71
Many abnormal PSA test results normalize over time.